- Home
- FRT vs BBIO Comparison
FRT vs BBIO Comparison
Compare FRT & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRT
- BBIO
- Stock Information
- Founded
- FRT 1962
- BBIO 2015
- Country
- FRT United States
- BBIO United States
- Employees
- FRT N/A
- BBIO N/A
- Industry
- FRT Real Estate Investment Trusts
- BBIO Biotechnology: Pharmaceutical Preparations
- Sector
- FRT Real Estate
- BBIO Health Care
- Exchange
- FRT Nasdaq
- BBIO Nasdaq
- Market Cap
- FRT 8.2B
- BBIO 9.4B
- IPO Year
- FRT N/A
- BBIO 2019
- Fundamental
- Price
- FRT $97.36
- BBIO $55.32
- Analyst Decision
- FRT Buy
- BBIO Strong Buy
- Analyst Count
- FRT 13
- BBIO 16
- Target Price
- FRT $110.08
- BBIO $64.44
- AVG Volume (30 Days)
- FRT 548.0K
- BBIO 2.0M
- Earning Date
- FRT 10-31-2025
- BBIO 11-11-2025
- Dividend Yield
- FRT 4.52%
- BBIO N/A
- EPS Growth
- FRT 16.00
- BBIO N/A
- EPS
- FRT 3.96
- BBIO N/A
- Revenue
- FRT $1,239,059,000.00
- BBIO $235,812,000.00
- Revenue This Year
- FRT $5.51
- BBIO $115.46
- Revenue Next Year
- FRT $5.35
- BBIO $65.03
- P/E Ratio
- FRT $24.58
- BBIO N/A
- Revenue Growth
- FRT 6.05
- BBIO 7.62
- 52 Week Low
- FRT $80.65
- BBIO $21.72
- 52 Week High
- FRT $118.09
- BBIO $55.30
- Technical
- Relative Strength Index (RSI)
- FRT 41.81
- BBIO 59.91
- Support Level
- FRT $98.03
- BBIO $52.97
- Resistance Level
- FRT $100.15
- BBIO $55.13
- Average True Range (ATR)
- FRT 1.18
- BBIO 1.58
- MACD
- FRT -0.50
- BBIO 0.16
- Stochastic Oscillator
- FRT 3.55
- BBIO 84.41
About FRT Federal Realty Investment Trust
Federal Realty Investment Trust is a shopping center-focused retail real estate investment trust that owns high-quality properties in eight of the largest metropolitan markets. Its portfolio includes an interest in 103 properties, which includes 27.5 million square feet of retail space and over 3,100 multifamily units. Federal's retail portfolio includes grocery-anchored centers, superregional centers, power centers, and mixed-use urban centers. Federal Realty has focused on owning assets in highly desirable areas with significant growth, and as a result, the average population density and average median household income are higher for its portfolio than for any other retail REIT.
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.